AG
ASND icon

Aperio Group’s Ascendis Pharma A/S ASND Stock Holding History

Aperio Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.11M Sell
6,639
-1,132
-15% -$187K ﹤0.01% 1543
2020
Q3 		$1.2M Buy
7,771
+256
+3% +$36.8K ﹤0.01% 1351
2020
Q2 		$1.11M Buy
7,515
+1,761
+31% +$242K ﹤0.01% 1365
2020
Q1 		$648K Sell
5,754
-698
-11% -$90.7K ﹤0.01% 1508
2019
Q4 		$898K Buy
6,452
+1,505
+30% +$167K ﹤0.01% 1488
2019
Q3 		$476K Buy
4,947
+365
+8% +$40.7K ﹤0.01% 1780
2019
Q2 		$528K Buy
4,582
+147
+3% +$17.6K ﹤0.01% 1760
2019
Q1 		$522K Sell
4,435
-1,712
-28% -$150K ﹤0.01% 1730
2018
Q4 		$385K Sell
6,147
-786
-11% -$49.4K ﹤0.01% 1837
2018
Q3 		$491K Buy
6,933
+431
+7% +$29.7K ﹤0.01% 1770
2018
Q2 		$433K Sell
6,502
-3,557
-35% -$234K ﹤0.01% 1814
2018
Q1 		$658K Buy
10,059
+3,191
+46% +$179K ﹤0.01% 1560
2017
Q4 		$275K Buy
6,868
+209
+3% +$7.6K ﹤0.01% 1990
2017
Q3 		$241K Buy
+6,659
New +$191K ﹤0.01% 2042
2017
Q2 		– Sell
-7,242
Closed -$203K – 2210
2017
Q1 		$203K Buy
+7,242
New +$183K ﹤0.01% 2032

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Aperio Group's ASND Position: Q4 2020 in Review

Aperio Group reduced its Ascendis Pharma A/S (ASND) stake by 15% in Q4 2020, selling an estimated $187K and leaving 6,639 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Aperio Group first reported a position in ASND in Q1 2017 and has held it in 15 quarters since. The position peaked at $1.2M in Q3 2020. 173 funds tracked by Wall St. Rank hold ASND as of Q4 2020.

  • Aperio Group held 6,639 shares of Ascendis Pharma A/S worth $1.11M as of Q4 2020.
  • Aperio Group sold 1,132 Ascendis Pharma A/S shares in Q4 2020, an estimated $187K.
  • Ascendis Pharma A/S made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1543 holding.
  • Aperio Group first reported a position in Ascendis Pharma A/S in Q1 2017 and has held it in 15 quarters since.
  • Aperio Group's Ascendis Pharma A/S position peaked at $1.2M in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.